摘要
为评价青光眼减压阀引流术治疗新生血管性青光眼，在视网膜血管性疾病、糖尿病、眼外伤所致的新生血管性青光眼２９例２９眼施行青光眼减压阀引流术，植入Ａｈｍｅｄ减压阀２０眼，Ｋｒｕｐｉｎ减压阀９眼。青光眼控制标准为６ｍｍＨｇ≤眼压≤２１ｍｍＨｇ，视功能保持或有所改善。结果：手术总成功率７５．８６％，眼压从术前平均５２．５６±１４．５１ｍｍＨｇ下降到２０．１５±１３．２６ｍｍＨｇ，平均随访１７．８３个月。有７眼在眼压正常后虹膜新生血管完全消退。术后３个月成功率７９．３１％，６个月成功率７６．１９％，１年成功率６６．６７％。主要手术并发症有前房导管口阻塞１３．７９％，浅前房１０．３４％，前房出血３．４５％。结论：青光眼减压阀引流术治疗新生血管性青光眼获得较为满意的疗效，是目前值得推荐的治疗选择。
Purpose:To evaluate glaucoma valve devices for filtration surgery in eyes with neovascular glaucoma.Methods:The Ahmed and Krupin glaucoma valve devices,were implanted in 20 and 9 eyes respectively,for 29 cases of neovascular glaucoma caused by retinal vascular diseases,diabetic retinopathy and severe ocular trauma.The criteria for success included a postoperative intraocular pressure of ≤21mmHg and ≥6mmHg and maintenance of vision.Results:The total success rate was 75 86% and the average intraocular pressure decreased from 52 56±14 51mmHg preoperatively to 20 15±13 26mmHg postoperatvely over a mean follow up of 17 83 months.In 7 eyes rubeosis iridis had completely disappeared after surgery controlled the intraocular pressure bringing it to normal levels.There was a success rate of 79 31% at 3 months,76 19% at 6 months and 66 67% at year.Occlusion of the tube tip occured in the anterior chamber in 4 eyes,the postoperative shallow chamber in 3 eyes and the hyphema in 1 eye.Conclusion:Satisfactory success for glaucoma control was achieved in this study and the glaucoma valve devices are recommended as the treatment of choice for neovascular glaucoma.
出处
《中国实用眼科杂志》
CSCD
1999年第5期272-274,共3页
Chinese Journal of Practical Ophthalmology
